Lv4
670 积分 2021-10-12 加入
D3S-001 in advanced solid tumors with KRASG12C mutations: a phase 1 trial
1天前
待确认
In vivo dendritic cell reprogramming for cancer immunotherapy
4个月前
已完结
Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction
11个月前
已完结
Enhanced stability of oral insulin in targeted peptide ligand trimethyl chitosan nanoparticles against trypsin
1年前
已完结
Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology
1年前
已完结
National trends in prescription drug expenditures and projections for 2023
1年前
已完结
MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study
1年前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
1年前
已完结
The multiple pathways to autoimmunity
1年前
已完结
皖公网安备34019202002308
